论文部分内容阅读
自1967年Shidd 首次应用丝裂霉素C(MMC)治疗膀胱癌取得令人鼓舞的结果以来有关文献报道日益增多。我院从1984年7月～1991年7月,应用MMC 膀胱灌注31例膀胱肿瘤术后患者,效果明显,现报告如下。病例与方法一、一般资料本组病例中,男26例,女5例;年龄29～78岁,平均56岁。膀胱内多发性肿瘤11例,单发性肿瘤20例;有蒂23例,无蒂8例;31例经膀胱局部肿瘤电灼20例,部份切除术11例。术后病理检查,31例均为膀胱移行
Increasing literature has been reported since the first encouraging application of mitomycin C (MMC) to bladder cancer in 1967. Our hospital from July 1984 to July 1991, MMC bladder perfusion 31 cases of bladder cancer patients, the effect is obvious, are as follows. Cases and methods First, the general information in this group of patients, 26 males and 5 females; aged 29 to 78 years, mean 56 years. Bladder tumors in 11 cases, solitary tumors in 20 cases; pedicle in 23 cases, no pedicle in 8 cases; 31 cases of local tumor by electrocautery in 20 cases, partial resection in 11 cases. Postoperative pathological examination, 31 cases were bladder transitional